The human sebaceous gland undergoes both extrinsic and intrinsic ageing. The latter is associated with morphological changes and alteration in the sebaceous gland activity. The high androgen-dependent sebum secretion in neonates falls during childhood, starts to rise again during puberty and reaches its maximum in young adults. While the number of sebaceous glands remains the same during life, sebum levels tend to decrease after menopause in females, whereas no major changes appear until the eighth decade of life in men. Reduced androgen levels in aged individuals lead to a slow cellular turnover in the sebaceous glands resulting in hyperplasia of the facial sebaceous glands in advanced age. Ultraviolet radiation and immune suppression (cyclosporin A with corticosteroids) represent cofactors for the development of sebaceous gland hyperplasia. Current molecular findings indicate that overexpression of the ageing-associated gene Smad7 and parathormone-related protein correlate with sebaceous gland hyperplasia, whereas c-myc overexpression is associated with enhanced sebum production. On the other hand, down-regulation of the mismatch repair genes hMLH-1 and hMSH-2 may promote the development of sebaceous gland carcinoma. In addition to spontaneous single tumours, sebaceous gland carcinomas have been reported in immune-suppressed transplant recipients (azathiorpine, cisplatin, cyclosporin A) and in association with the Muir±Torre syndrome. Microsatellite instability with a loss of the mismatch repair gene hMSH-2 has been detected in immune suppressed patients and under photo-induced DNA damage. Topical and systemic oestrogens offer treatment options for skin xerosis in menopausal females. A combination of isotretinoin and interferon-a may prevent tumour development in patients with Muir±Torre syndrome.
Introduction
Skin represents the major organ in which changes of ageing are visible. Skin ageing is attributed to both intrinsic, genetically determined (chronological ageing) and extrinsic, environmental factors. While chronological ageing is regulated mainly by androgens and other hormones, almost 90% of skin changes due to environmental influence are caused by chronic sun exposure (photoageing). 1 The process of photoageing in elderly adults goes along with characteristic clinical and histological changes associated with the magnitude of cumulative sun exposure which differ from alterations in chronologically aged, but sun-protected skin. 2 Among several skin compartments influenced by the ageing process, the sebaceous glands are affected by both intrinsic and environmental factors.
Morphological changes in sebaceous glands associated with chronological ageing
Pilosebaceous units are formed during embryonic life between 2 and 4 months of gestation; the sebaceous glands arise in a cephalo-caudal sequence from hair follicles. 3, 4 Sebaceous glands are well developed in neonates but their size decreases dramatically a few weeks after birth and they are almost undetectable during childhood. 5, 6 Their size increases again with the adrenarche, develops further with the onset of puberty, reaches its maximum at the third decade of life, remains constant until middle age, and tends to decrease slowly at the seventh decade. Generally, the number of sebaceous glands remains approximately the same throughout life, whereas their size tends to change with age. 7 An apparent paradox is that in ageing facial skin, the sebaceous gland volume increases, whereas no obvious morphological abnormalities occur.
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Age-associated alterations in sebaceous gland activity
The activity of the sebaceous glands shows age-related differences established by qualitative and quantitative analysis of sebum. 6, 9, 10 During embryonic life, maternal stimulation of the embryonic pituitary±adrenal axis leads to increased adrenal volume in the embryo and enhanced secretion of dehydroepiandrosterone (DHEA). 11±13 There are indications that these events result in a consecutive up-regulation of the androgen metabolic machinery in the sebaceous gland cells, 14 intracellular 5a-dihydrotestosterone (5a-DHT) synthesis, sebaceous gland hypetrophy, and production of sebum that forms the vernix caseosa of embryonic skin. As a result, sebaceous gland secretion is high in neonates but falls a few weeks after birth and remains low during childhood. 5, 6, 15 It is noticeable that a direct link was found between maternal and neonatal sebum excretion rates in the perinatal time suggesting that they respond similarly to identical hormonal environments. 5 Related to DHEA production, the sebum secretion starts to rise once more with adrenarche to be increased further during puberty, reaching a maximum in young adults.
6,9,15±17 Thereafter there is no recognized change until the menopause/climacterium virile. 6 In elderly adults the sebaceous gland activity is sex dependent. In men, no change in sebum production appears until the eighth decade of life and generally sebum production is still comparable to that of young persons. 6, 15 In oestrogen nonsubstituted women the sebum levels start to fall gradually after the menopause. In the sixth decade they drop by 40% and continue to fall in the seventh decade after which no further decline is established. 6 In facial skin, the levels of skin surface lipids in the elderly are similar to those of prepubertal children, whereas generally the mean sebum levels in females are reduced more than in males. 6, 7, 9 The differences in sebum secretion at various times of life are associated mainly with concomitant changes in endogenous androgen production. 6, 15 Although sebaceous gland activity is decreased in aged skin, there is still a capacity of both sexes to respond to externally given androgens by increasing sebum levels. 6 The sebaceous gland cells are normally completely renewed every month. 18 Reduced androgen levels lead to a decreased cellular turnover in aged sebaceous glands of the face resulting in glandular hyperplasia in the elderly.
6±8 Therefore, in contrast with the age-related reduced secretory output of the sebaceous glands with a decrease in surface lipid levels, the size of the facial sebaceous glands increases rather than decreases.
Influence of photoageing on the sebaceous glands
Photoageing has been associated with the development of benign and malignant sebaceous tumours. Prolonged ultraviolet radiation (UVR) has been shown to cause marked hyperplasia of the sebaceous glands in hairless mice. 19 Interestingly, as reported above, sebaceous gland hyperplasia develops mainly in ageing facial skin. UVR probably represents a cofactor, because sebaceous gland hyperplasia also occurs in the oral mucosa of elderly persons, where sunlight is not a relevant issue. 7 High cumulative exposure to UVR has also been implicated in the development of sebaceous gland carcinoma, as it is often located on the head and neck area. 20 The damaging effect of UVR on sebaceous glands is currently considered to be far more critical than it was suspected in the past and has been attributed to UVA, as UVA penetrates deeper into the dermis and can reach the sebaceous gland. 21 
Clinical signs of ageing-related changes of sebaceous glands and their activity
The major clinical manifestations associated with ageing changes of the sebaceous glands are skin xerosis, as well as sebaceous gland hyperplasia and sebaceous carcinoma in areas with sebaceous follicles (face and upper trunk). In addition, increased prevalence of sebaceous gland hyperplasia as well as of benign and malignant sebaceous gland tumours has been reported in immune suppressed patients. 20, 22 Generalized skin xerosis is a frequent clinical problem in late adolescence, as a result of a reduced production Chronological ageing and photoageing of the human sebaceous gland X C. C. Zouboulis and A. Boschnakow of sebum combined with a decrease of eccrine sweat output. 7 Sebaceous gland hyperplasia can vary in size. The lesions occur as yellowish or skin-coloured papules and nodules, sometimes with large dilated follicular openings, where sebum can be squeezed out (Figs 1±4). 21 Sebaceous gland carcinoma is a rare cutaneous tumour with an incidence of approximately 0.2% of all skin malignancies. 21 It occurs sporadically and can develop in every sebaceous gland, with a predilection to UVR-exposed skin areas, such as the eyelids, the neck and the head. 20, 23 UVR and a human papilloma virus infection have been suggested as causative factors. 20, 24 Clinically, the tumour may appear initially as a yellowish papule or nodule and can hardly be differentiated from initial stage benign sebaceous gland hypetrophy or from other epithelial tumours at later stages. 25 In most cases it appears in the seventh to ninth decade of life. 23 Diagnosis is usually established by histopathological investigation (Figs 5 and 6 ). Sebaceous gland carcinoma tends to metastasize early to local lymph nodes and to the bones.
Sebaceous gland carcinoma can also occur in the context of a syndrome of tumours in association with internal malignancies 2 the Muir±Torre syndrome. 23, 25 Since the first report by Muir and Torre in 1967, more than 150 cases have been documented. The syndrome is characterized by the presence of multiple sebaceous gland epitheliomas and adenomas, multiple keratoacanthomas, sebaceous gland carcinoma (in 30% of the cases) and visceral tumours. 23 The latter are detected predominantly at the gastrointestinal system (50%; e.g. herediatary nonpolyposis colorectal carcinoma). Genitourinary system (21%), mammary gland (10%) and haematological malignancies can also occur. 23, 25 Patients with Muir±Torre syndrome develop sebaceous carcinomas on sun-exposed, but not on sun-protected, skin areas; therefore, it has been suggested that a photoinduced DNA damage may influence the mismatch repair genes and promote the tumours. 20 The diagnosis of a sebaceous carcinoma must be followed by a thorough clinical examination of the patient as well as of members of his family, to distinguish between patients with sporadic sebaceous gland carcinoma and a sebaceous gland carcinoma as a sign of Muir±Torre syndrome, and to perform genetic counselling.
Iatrogenic sebaceous gland hyperplasia and sebaceous carcinoma
While rating 1% in a healthy population, sebaceous gland hyperplasia occurs in 16% of immune suppressed organ transplant recipients. 22 The majority of the latter patients had received long-term cyclosporin A treatment alone or in combination with corticosteroids (Fig. 7) . Interestingly, no higher incidence of hypertrichosis could be observed in these patients. Increased rates of sporadic sebaceous gland carcinoma as a single tumour or in association with internal malignancies and other signs of Muir±Torre syndrome have also been reported in immune suppressed transplant recipients. 20 It seems likely, therefore, that iatrogenic immunosuppession may release an abnormal proliferation and differentiation of the sebaceous glands in sebaceous follicles.
Molecular findings associated with sebaceous gland activity
In the uropegial gland of the duck, a sebaceous gland-like organ, 17b-estradiol has been shown to induce metabolism of prostaglandin D2 to D12-prostaglandin J2 which is the most potent natural ligand for peroxisome proliferator-activated receptor (PPAR)-g1. 26, 27 Regulation of PPARs has been shown to be responsible for lipid synthesis in cells of the rat preputial gland, an organ that has been proposed to differentiate in a manner similar to that of the sebaceous gland. 28 On the other hand, oestrogens suppress enhanced sebaceous gland function directly. 16 It is likely, therefore, that oestrogens exhibit a biphasic activity and that oestrogen insufficiency may lead to reduced sebaceous lipid production. In addition, 17b-estradiol seems to regulate keratinocyte proliferation through the insulin-like growth factor-1/insulin-like growth factor-1 receptor pathway and to stimulate collagen synthesis.
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Androgens are required for growth of sebaceous gland cells but they interact with PPARs, and less directly with many other factors, to stimulate their differentiation. 16, 28, 32, 33 These findings may partially explain the dissociation of sebaceous gland cell proliferation and differentiation observed in aged skin.
Further factors have been shown to affect sebaceous gland cell differentiation and may therefore be responsible for the reduced sebaceous gland activity in elderly patients. Among them, growth hormone, the levels of which decline with age, markedly induced lipid synthesis in rat preputial gland in vitro and augmented the similar effect of 5a-DHT. 34 On the other hand, acromegaly is known to be associated with seborrhea. 35 Several genes have currently been shown to regulate sebaceous gland function in genetic studies. Overexpression of Smad7 in adult transgenic mice has been correlated with hyperplasia of the sebaceous gland.
36 Smad7 blocks signal transduction of the transforming growth factor-b superfamily. On the other hand, c-myc overexpression was also shown to be associated with enhanced sebaceous lipid synthesis, 37 whereas c-myc expression shows a drastic decrease with age. Parathormone-related protein (PTHrP) knock-out mice presented hypoplastic sebaceous glands, whereas PTHrP overexpression led to sebaceous gland hyperplasia. 38 The Muir±Torre syndrome is an autosomal dominant genetic disease and therefore a positive family history is to be expected. 39 Up to 31% of mutation carriers can be symptomatic in certain families. A microsatellite instability in sebaceous gland tumours and a loss of expression of the mismatch repair genes hMLH-1 and hMSH-2 are diagnostic markers for Muir±Torre syndrome. 23 The role of microsatellite instability in sporadic sebaceous gland carcinoma is still not established. 20 The mismatch repair genes are responsible for the correction of small errors in repeat sequences of DNA (microsatellites) that happens in the time of replication. A deficiency of mismatch repair genes leads to a mircosatellite instability with an accumulation of mutational microsatellites.
A microsatellite instability was also identified in organ transplant recipients under immune-suppressing medication. The microsatellite instability in these immune incompetent patients also went along with a loss of mismatch repair gene hMSH-2 expression. 20 These findings suggest that immune suppressive treatment may promote sebocytes to induce tumour progression in genetically susceptible patients.
At last, the proposal of sebaceous carcinoma development in human papilloma virus-infected patients takes into consideration a mutational inactivation of the tumour suppressor gene p53 by the virus that leads to tumour progression. 24 
Treatment of age-associated sebaceous gland diseases
Topical oestrogen treatment of facial skin in menopausal females results in an induction of the sebaceous gland activity with increased sebum secretion. 40 A significant reduction in skin xerosis was found in menopausal white-skinned females under oestrogen substitution, whereas in studies of testosterone substitution in elderly males no marked improvement of skin quality was reported. 41 The treatment of sebaceous carcinoma is the surgical intervention. Combined treatment with isotretinoin and interferon-a appears to be successful in preventing cancer development in patients with Muir±Torre syndrome. 39 Aspirin and other nonsteroidal antiinflammatory drugs can reduce microsatellite instability in mismatch repair-deficient cells and may be promising for effective prophylaxis of tumours in Muir±Torre syndrome. 42 An immune suppressive treatment with cisplatin and azathioprine should be avoided in patients with sebaceous gland hyperplasia and those who are genetically prone to develop sebaceous gland carcinoma, because these compounds have been shown to interact with DNA mismatch repair proteins followed by the emergence of a mutated phenotype. 20, 42 
